Disclosure 0002020969-26-000006-1

SEC FORM 4

$254,373.68

RECURSION PHARMACEUTICALS, INC. (RXRX)

Disposition (code F) of 80,498 shares at $3.16 per share.

Reporting Person Khan Najat · Officer Title CEO and President · Transaction Code F

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0002020969-26-000006 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "RECURSION PHARMACEUTICALS, INC. (RXRX)." Disclosed 2026-08-18. https://desqlong.com/cards/0002020969-26-000006-1 (retrieved 2026-09-26).